Innovo Therapeutics
PrivateLast Round
Early Funding
Dec 1, 2023
Total Funding Raised
$28.84M
Company Overview
Innovo Therapeutics, Inc. is a biotechnology company based in San Diego, California, that specializes in the discovery and development of novel protein degrader drugs for cancer treatment. The company focuses on creating anti-cancer therapeutics using targeted protein degradation technology. Incorporated in 2020, Innovo Therapeutics aims to provide more innovative and effective treatment options for tumors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innovo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Innovo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 1, 2023 | ||||
| Angel | May 15, 2022 |
Innovo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qiandao Fund | Early Funding |
| Ming Bioventures | Early Funding, Angel |
| Huajin Capital | Early Funding |
Innovo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innovo Therapeutics's valuation, stock price, and market status.
